Publication:
Better data, better policy and better lives: a call for improved drug monitoring and concerted responses.

Simple item page
dc.contributor.authorComiskey, Catherine
dc.contributor.authorBretteville-Jensen, Anne Line
dc.contributor.authorBergeron, Henri
dc.contributor.authorBühringer, Gerhard
dc.contributor.authorDargan, Paul
dc.contributor.authorDavoli, Marina
dc.contributor.authorFaggiano, Fabrizio
dc.contributor.authorFischer, Gabriele
dc.contributor.authorRodriguez-de-Fonseca, Fernando
dc.contributor.authorGarretsen, Henk
dc.contributor.authorHickman, Matthew
dc.contributor.authorKorf, Dirk J
dc.contributor.authorKrajewski, Krzysztof
dc.contributor.authorPaoli, Letizia
dc.contributor.authorSpanagel, Rainer
dc.date.accessioned2023-01-25T13:37:55Z
dc.date.available2023-01-25T13:37:55Z
dc.date.issued2019-06-06
dc.description.abstractWith the breadth of new psychoactive substances andinternational policy changes, an analysis of specificresponses in all areas of drug supply and demand is beyondthe resources of a single country. The Scientific Committee ofthe European Monitoring Centre for Drugs and DrugAddiction calls for a strengthening of global monitoring andevidence synthesis and a renewed vigour in collaborativeefforts to expand training, research and the quality andcomparability of data across Europe and beyond.
dc.description.versionSi
dc.identifier.citationComiskey C, Bretteville-Jensen AL, Bergeron H, Bühringer G, Dargan P, Davoli M, et al. Better data, better policy and better lives: a call for improved drug monitoring and concerted responses. Addiction. 2020 Feb;115(2):199-200
dc.identifier.doi10.1111/add.14763
dc.identifier.essn1360-0443
dc.identifier.pmid31353676
dc.identifier.unpaywallURLhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/add.14763
dc.identifier.urihttp://hdl.handle.net/10668/14323
dc.issue.number2
dc.journal.titleAddiction (Abingdon, England)
dc.journal.titleabbreviationAddiction
dc.language.isoen
dc.organizationHospital Universitario Regional de Málaga
dc.organizationFundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud-FIMABIS
dc.page.number199-200
dc.provenanceRealizada la curación de contenido 21/02/2025
dc.publisherWiley
dc.pubmedtypeEditorial
dc.relation.publisherversionhttps://doi.org/10.1111/add.14763
dc.rights.accessRightsRestricted Access
dc.subjectData
dc.subjectNew psychoactive substances
dc.subjectEvaluation
dc.subjectMonitoring
dc.subjectPolicy
dc.subjectTraining
dc.subject.decsMonitoreo del ambiente
dc.subject.decsPreparaciones farmacéuticas
dc.subject.decsAprovisionamiento
dc.subject.decsRecursos en salud
dc.subject.decsTutoría
dc.subject.meshAdvisory Committees
dc.subject.meshDrug and Narcotic Control
dc.subject.meshEpidemiological Monitoring
dc.subject.meshEuropean Union
dc.subject.meshHumans
dc.subject.meshInternational Cooperation
dc.subject.meshPsychotropic Drugs
dc.subject.meshPublic Health Surveillance
dc.subject.meshPublic Policy
dc.titleBetter data, better policy and better lives: a call for improved drug monitoring and concerted responses.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number115
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
RISalud_Accesorestringido.pdf
Size:
93.39 KB
Format:
Adobe Portable Document Format
Download

Collections

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS)
SAS - Hospital Regional Universitario de Málaga

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía